Placental Growth Factor in Patients with Decreased Renal Function (Q57825192)

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Premature cardiovascular disease in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Expression and function of placenta growth factor: implications for abnormal placentation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Expression of vascular endothelial growth factor and placenta growth factor in human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Placenta growth factor is over-expressed and has prognostic value in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Placenta growth factor activates monocytes and correlates with sickle cell disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Urinary Placental Growth Factor and Risk of Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Potential role for plasma placental growth factor in predicting coronary heart disease risk in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Quantitation of dialysis. The importance of membrane and middle molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Elevated levels of placental growth factor represent an adaptive host response in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Statin effects beyond lipid lowering--are they clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402

Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.560402